Phase 2 study of nivolumab (anti-programmed death-1 [PD-1]) in patients (pts) with advanced, refractory squamous (SQ) non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Zalcman, G.; Rizvi, N. A.; Lena, H.; Wolf, J.; Mazieres, J.; Antonia, S. J.; Minenza, E.; Planchard, D.; Lestini, B. J.; Ramalingam, S. S. |
| Abstract Title: | Phase 2 study of nivolumab (anti-programmed death-1 [PD-1]) in patients (pts) with advanced, refractory squamous (SQ) non-small cell lung cancer (NSCLC) |
| Meeting Title: | 5th European Lung Cancer Conference (ELCC) |
| Journal Title: | Annals of Oncology |
| Volume: | 26 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2015 Apr 15-18 |
| Meeting Location: | Geneva, Switzerland |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2015-04-01 |
| Start Page: | i32 |
| End Page: | i33 |
| Language: | English |
| ACCESSION: | WOS:000354728700046 |
| DOI: | 10.1093/annonc/mdv050.08 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 104PD -- Source: Wos |
